Académique Documents
Professionnel Documents
Culture Documents
(HMC)
View: Annual Data | Quarterly Data
Period Ending
15,432,000
11,985,000
6,990,000
Net Receivables
25,592,000
23,119,000
22,521,000
Inventory
10,857,000
10,013,000
12,595,000
4,708,000
4,259,000
4,682,000
56,588,000
49,376,000
46,787,000
36,062,000
32,149,000
30,772,000
39,781,000
36,332,000
34,783,000
Goodwill
Intangible Assets
Accumulated Amortization
7,179,000
6,599,000
7,319,000
139,610,000
124,455,000
119,661,000
Accounts Payable
15,071,000
14,650,000
12,856,000
25,126,000
19,406,000
27,500,000
2,857,000
2,535,000
2,545,000
43,053,000
36,592,000
42,901,000
24,653,000
24,754,000
19,567,000
Assets
Current Assets
Cash And Cash Equivalents
Short Term Investments
Other Assets
Deferred Long Term Asset Charges
Total Assets
Liabilities
Current Liabilities
Other Liabilities
16,609,000
15,417,000
15,375,000
4,041,390
1,604,000
1,368,000
1,246,000
85,918,000
78,130,000
79,089,000
Preferred Stock
Common Stock
1,038,000
921,000
871,000
68,370,000
56,769,000
51,628,000
Retained Earnings
Treasury Stock
Capital Surplus
(315,000)
(768,000)
(726,000)
2,082,000
1,846,000
1,747,000
(17,484,000)
(12,443,000)
(12,948,000)
53,692,000
46,325,000
40,572,000
53,692,000
46,325,000
40,572,000
Income Statement
Period Ending
Total Revenue
107,829,000
91,815,000
101,359,000
Cost of Revenue
78,389,000
68,651,000
75,120,000
Gross Profit
29,440,000
23,164,000
26,239,000
Operating Expenses
Research Development
5,883,000
4,959,000
5,702,000
16,683,000
14,312,000
18,617,000
Non Recurring
Others
6,875,000
3,893,000
1,920,000
835,000
(161,000)
(55,000)
7,710,000
3,732,000
1,865,000
102,000
134,000
228,000
7,608,000
3,598,000
1,637,000
2,495,000
1,572,000
1,112,000
Interest Expense
Minority Interest
Net Income From Continuing Ops
(355,000)
(152,000)
(141,000)
6,444,000
2,872,000
1,387,000
Discontinued Operations
Extraordinary Items
Other Items
6,444,000
2,872,000
1,387,000
6,444,000
2,872,000
Non-recurring Events
Net Income
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares
1,387,000
Period Ending
2,033,200
1,413,600
450,000
252,700
246,300
16,400
Net Receivables
3,072,200
3,150,100
2,399,200
Inventory
3,129,200
2,465,200
2,127,800
1,330,400
943,900
710,500
9,817,700
8,219,100
5,703,900
2,741,900
2,607,300
2,073,900
5,213,100
4,970,000
4,316,200
84,300
78,400
105,500
4,477,000
3,445,800
2,488,200
Other Assets
558,400
781,200
653,800
238,600
132,300
84,300
23,131,000
20,234,100
15,425,800
Accounts Payable
5,208,400
4,128,300
3,071,700
4,170,700
4,995,100
6,300,000
2,927,800
3,226,200
2,118,900
Assets
Current Assets
Cash And Cash Equivalents
Short Term Investments
Goodwill
Intangible Assets
Accumulated Amortization
Total Assets
Liabilities
Current Liabilities
12,306,800
12,349,600
11,490,600
4,517,800
4,430,300
2,290,100
Other Liabilities
1,256,000
873,600
727,700
313,100
303,700
154,200
53,600
45,600
82,400
18,447,300
18,002,800
14,744,900
Preferred Stock
Common Stock
142,300
127,100
101,300
1,012,100
94,100
(552,000)
Treasury Stock
Capital Surplus
3,935,100
2,572,600
1,540,700
Retained Earnings
(405,800)
4,683,700
122,400
(562,400)
2,231,400
680,900
(1,292,800)
(1,912,800)
GO
Income Statement
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
(409,200)
27,629,400
20,631,800
14,246,700
2,713,300
2,157,000
1,404,600
24,916,100
18,474,700
12,842,100
Research Development
Selling General and Administrative
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss
68,500
21,132,000
16,584,700
12,149,500
974,200
816,100
552,700
11,877,400
2,809,900
1,074,000
139,900
(893,300)
991,900
(646,700)
2,766,900
2,065,900
(506,800)
826,400
899,800
1,940,500
1,166,100
286,700
329,000
16,600
1,653,700
837,100
Discontinued Operations
Extraordinary Items
Other Items
1,653,700
837,100
1,653,700
837,100
(43,000)
674,500
(1,181,300)
(1,197,900)
Non-recurring Events
Net Income
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares
(1,197,900)
(1,197,900)